These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 4797027

  • 1. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
    Le Mevel BP, Oldham RK, Wells SA, Herberman RB.
    J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
    [No Abstract] [Full Text] [Related]

  • 2. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F, Yaakubovicz M, Witz IP.
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract] [Full Text] [Related]

  • 3. Quantitation of cytotoxic antitumor antibody in vitro: a microassay with 125I-iododeoxyuridine as a tumor cell label.
    Fritze D, Kern DH, Pilch YH.
    J Natl Cancer Inst; 1974 Nov; 53(5):1403-7. PubMed ID: 4431057
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.
    Fossati G, Holden HT, Herberman RB.
    Cancer Res; 1975 Sep; 35(9):2600-8. PubMed ID: 167966
    [Abstract] [Full Text] [Related]

  • 5. Cell loss from several types of solid murine tumour: comparison of 125I-iododeoxyuridine and tritiated thymidine methods.
    Begg AC.
    Cell Tissue Kinet; 1977 Sep; 10(5):409-27. PubMed ID: 922795
    [No Abstract] [Full Text] [Related]

  • 6. Radioactively labeled iododeoxyuridine in the study of experimental liver regeneration.
    Bürki K, Schaer JC, Grétillat P, Schindler R.
    Curr Top Pathol; 1975 Sep; 60():33-61. PubMed ID: 1104278
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC, Nunn ME, Park JY, Herberman RB.
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells.
    Oldham RK, Herberman RB.
    J Immunol; 1973 Dec; 111(6):862-71. PubMed ID: 4750872
    [No Abstract] [Full Text] [Related]

  • 9. Study of a microassay for the quantitation of cytotoxic antitumor antibody, using 125I-iododeoxyuridine as a target cell label; detection of a static effect on cell DNA synthesis.
    Le Mevel BP, Wells SA.
    Biomedicine; 1976 Dec 15; 24(6):434-42. PubMed ID: 1022316
    [Abstract] [Full Text] [Related]

  • 10. Studies on the microcytotoxicity test. II. The uptake of amino acids ([3H]leucine or [75Se]methionine) but not nucleosides ([3H]thymidine or [125I]IUdR) or 51CrO24-provides a direct and quantitative measure of target cell survival in the presence of lymphoid cells.
    Brooks CG, Rees RC, Robins RA.
    J Immunol Methods; 1978 Dec 15; 21(1-2):111-24. PubMed ID: 659896
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A lymphocytotoxicity assay not requiring the in vitro culture of target tumor cells.
    Kreider JW, Flickinger JT, Lengle N, Shoff W.
    Transplantation; 1974 Sep 15; 18(3):223-8. PubMed ID: 4422190
    [No Abstract] [Full Text] [Related]

  • 14. Cytocidal effect of rifamycin derivatives on ascites tumor cells: studies with [125I]iododeoxyuridine.
    Hughes AM, Calvin M.
    Cancer Lett; 1979 Jan 15; 6(1):15-9. PubMed ID: 544007
    [Abstract] [Full Text] [Related]

  • 15. Kinetics of micronuclei induced by 125IdU in cells of two lines.
    Ludwików G, Ludwików F, Johanson KJ.
    Radiat Res; 1994 Apr 15; 138(1):70-8. PubMed ID: 8146302
    [Abstract] [Full Text] [Related]

  • 16. Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays.
    Wiltrout RH, Frost P, Cummings GD.
    J Natl Cancer Inst; 1978 Jul 15; 61(1):183-8. PubMed ID: 97392
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters.
    Bloomer WD, Adelstein SJ.
    Nature; 1977 Feb 17; 265(5595):620-1. PubMed ID: 859560
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.